Patents by Inventor Fiona M. Ellard

Fiona M. Ellard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7718627
    Abstract: A vector comprising a nucleotide sequence of interest (“NOI”) encoding a product of interest (“POI”) is described. The NOI and/or the POI is capable of recognizing a tumor, such that in use the vector is capable of delivering the NOI and/or the POI to the tumor.
    Type: Grant
    Filed: April 25, 2006
    Date of Patent: May 18, 2010
    Assignee: Oxford Biomedica (UK) Limited
    Inventors: Susan M. Kingsman, Christopher R. Bebbington, Fiona M. Ellard, Miles W. Carroll, Kevin A. Myers
  • Patent number: 7514546
    Abstract: The use of an ScFv Ab (ScFv Ab) capable of recognizing a disease associated molecule (DAM) in the manufacture of a medicament for the prevention and/or treatment of a disease condition associated with a DAM is described. The ScFv Ab has therapeutic, diagnostic and prognostic applications.
    Type: Grant
    Filed: April 26, 2006
    Date of Patent: April 7, 2009
    Assignee: Oxford BioMedica (UK) Ltd.
    Inventors: Susan Mary Kingsman, Christopher R. Bebbington, Miles W. Carroll, Fiona M. Ellard, Kevin A. Myers
  • Publication number: 20080175819
    Abstract: The present invention provides a vector system comprising a nucleotide sequence coding for an antibody. In particular, the present invention relates to the use of such a vector system in a subject, where the nucleotide sequence is expressed in vivo to produce said antibody.
    Type: Application
    Filed: August 6, 2007
    Publication date: July 24, 2008
    Applicant: Oxford BioMedica (UK) Limited
    Inventors: Alan J. Kingsman, Christopher R. Bebbington, Miles W. Carroll, Fiona M. Ellard, Susan M. Kingsman, Kevin A. Myers
  • Patent number: 7276488
    Abstract: The present invention provides a vector system comprising a nucleotide sequence coding for an antibody. In particular, the present invention relates to the use of such a vector system in a subject, where the nucleotide sequence is expressed in vivo to produce said antibody.
    Type: Grant
    Filed: January 29, 2002
    Date of Patent: October 2, 2007
    Assignee: Oxford Biomedica (UK) Limited
    Inventors: Alan J. Kingsman, Christopher R. Bebbington, Miles W. Carroll, Fiona M. Ellard, Susan M. Kingsman, Kevin A. Myers
  • Patent number: 6818209
    Abstract: A retroviral delivery system capable of transducing a target site is described. The retroviral delivery system comprises a first nucleotide sequence coding for at least a part of an envelope protein; and one or more other nucleotide sequences derivable from a retrovirus that ensure transduction of the target site by the retroviral delivery system; wherein the first nucleotide sequence is heterologous with respect to at least one of the other nucleotide sequences; and wherein the first nucleotide sequence codes for at least a part of a rabies G protein or a mutant, variant, derivative or fragment thereof that is capable or recognising the target site.
    Type: Grant
    Filed: November 22, 2000
    Date of Patent: November 16, 2004
    Assignee: Oxford Biomedica (UK) Limited
    Inventors: Kyriacos A. Mitrophanous, Deva Patil, Alan J. Kingsman, Susan M. Kingsman, Fiona M. Ellard
  • Publication number: 20030083290
    Abstract: The present invention provides a vector system comprising a nucleotide sequence coding for an antibody. In particular, the present invention relates to the use of such a vector system in a subject, where the nucleotide sequence is expressed in vivo to produce said antibody.
    Type: Application
    Filed: January 29, 2002
    Publication date: May 1, 2003
    Inventors: Alan J. Kingsman, Christopher R. Bebbington, Miles W. Carroll, Fiona M. Ellard, Susan M. Kingsman, Kevin A. Myers